by Brad N. Taylor, Ph.D. | Mar 9, 2023
CBM, Nucleus Biologics, and Stoic Bio have launched a collaborative partnership to expedite the sustainable development of CGT therapies. The Center for Breakthrough Medicine (CBM) is a contract development and manufacturing organization (CDMO) located within The...
by Brad N. Taylor, Ph.D. | Mar 7, 2023
San Diego, CA, March 7, 2023 – In a joint effort to accelerate high-quality therapies to market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom cell culture media solutions for the cell and gene therapy industry, and Stoic Bio, a...
by Brad N. Taylor, Ph.D. | Feb 16, 2023
The emergence of organ-specific 3D tissue culture technology is a scientific breakthrough that promises a new era of disease research and discovery. Organoids are complex, 3-dimensional collections of cells grown in culture to mimic the organization of human organs....
by Brad N. Taylor, Ph.D. | Dec 20, 2022
In celebration of the holidays, we take a look back at some of the most exciting events and achievements of the year…and a look forward to what the New Year will bring. Science enthusiasts everywhere, your attention please! Today we thank the hardworking team at...
by Brad N. Taylor, Ph.D. | Dec 12, 2022
CAR T therapy is a revolutionary new cancer treatment that relies on engineering a patient’s immune cells. High transduction efficiency is key to its therapeutic success. Nucleus Biologics has launched NB-ROC™, a serum free media formulated by T cell researchers with...
